Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

psilocin

Known as: (3-(2-dimethylamino)ethyl)indol-4-ol 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The main psychedelic component of magic mushrooms is psilocybin, which shows promise as a treatment for depression and other… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Psychedelic drugs produce profound changes in consciousness, but the underlying neurobiological mechanisms for this remain… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Abstract Aim. The study aimed to collect information concerning the increasing use of new psychoactive substances, commonly sold… Expand
Is this relevant?
Highly Cited
2012
Highly Cited
2012
The serotonin-2A receptor (5-HT2AR) has been implicated in the pathogenesis of schizophrenia and related inhibitory gating and… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
2004
2004
Summary1.Reactions induced by LSD, mescaline, psilocin, and psilocybin are qualitatively similar.2.The time course of the… Expand
Is this relevant?
2002
2002
In a clinical study eight volunteers received psilocybin (PY) in psychoactive oral doses of 212+/-25 microg/kg body weight. To… Expand
  • table 1
  • table 2
  • figure 2
  • figure 3
  • table 3
Is this relevant?
2001
2001
Pharmacokinetic studies of psilocybin in humans have shown the rapid dephosphorylation of psilocybin to psilocin with further… Expand
  • figure 1
  • figure 2
  • table 1
Is this relevant?
2000
2000
Active compounds of some mushrooms e.g. Psilocybe cubensis, Paneolus subalteatus or Stropharia coronilla, the psychotropic agents… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Highly Cited
1997
Highly Cited
1997
In order to investigate the pharmacokinetic properties of psilocybin (PY), the main psychoactive compound of Psilocybe mushrooms… Expand
Is this relevant?
1961
1961
Abstract Incubation of psilocybin with rat kidney homogenates caused a rapid liberation of its -OH congener, psilocin, through… Expand
Is this relevant?